{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:34:07Z","timestamp":1791092047151,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01 EO 0803"],"award-info":[{"award-number":["01 EO 0803"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["108935"],"award-info":[{"award-number":["108935"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jaci.2013.01.018","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T22:36:51Z","timestamp":1362436611000},"page":"1695-1699.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid"],"prefix":"10.1016","volume":"131","author":[{"given":"Anne-Kathrin","family":"Kienzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Eibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.01.018_bib1","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2013.01.018_bib2","first-page":"248","article-title":"The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma","volume":"91","author":"Kaiser","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2013.01.018_bib3","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-06-2903","article-title":"Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity","volume":"13","author":"Nencioni","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2013.01.018_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.552310","article-title":"Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression","volume":"24","author":"Yamaguchi","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2013.01.018_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20091706","article-title":"B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans","volume":"207","author":"Avery","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.01.018_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2249.2003.02097.x","article-title":"Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood","volume":"132","author":"Callenbach","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.01.018_bib7","article-title":"Valproate-induced panhypogammaglobulinemia","author":"Eom","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jaci.2013.01.018_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0306-3623(85)90207-1","article-title":"Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients","volume":"16","author":"Garzon","year":"1985","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jaci.2013.01.018_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis","volume":"63","author":"Vojinovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2013.01.018_bib10","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1002\/art.22211","article-title":"B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles","volume":"54","author":"Cambridge","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2013.01.018_bibE1","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.M112.356584","article-title":"The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis","volume":"l287","author":"Lv","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2013.01.018_bibE2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexmp.2009.06.003","article-title":"Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis","volume":"87","author":"Saouaf","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jaci.2013.01.018_bibE3","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s00018-008-8521-4","article-title":"Valproic acid attenuates inflammation in experimental autoimmune neuritis","volume":"65","author":"Zhang","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2013.01.018_bibE4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2002-07-2073","article-title":"Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression","volume":"101","author":"Skov","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.01.018_bibE5","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.4049\/jimmunol.0903610","article-title":"Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production","volume":"185","author":"Grausenburger","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.01.018_bibE6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2010.04.018","article-title":"Histone\/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs","volume":"136","author":"Akimova","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2013.01.018_bibE7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.01.018_bibE8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.01.018_bibE9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/eji.1830260226","article-title":"The phenotype and fate of the antibody-forming cells of the splenic foci","volume":"26","author":"Smith","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.01.018_bibE10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2013.01.018_bibE11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.184.1.277","article-title":"B cell differentiation and isotype switching is related to division cycle number","volume":"184","author":"Hodgkin","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.01.018_bibE12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory B and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2013.01.018_bibE13","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:41:51Z","timestamp":1758789711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0091674913001553"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.01.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}